Patent ID: 7879357

Claim:
A composition in the form of a hydrogel comprising 0.01-5.0% by weight of 7α-methyl-11β-fluoro-19-nortestosterone (eF-MENT), 0.1-1.5% by weight of acrylate/C 10-30 alkyl acrylate crosspolymer, 0-1.0% by weight of polyacrylic acid, 0.1-1.5% by weight of a cellulose derivative, 5.0-20.0% by weight of propylene carbonate, 0.01-5.0% by weight of glycerol, 0.01-5.0% by weight of cyclomethicone, 0.01-5.0% by weight of isopropyl myristate, 20.0-50.0% by weight of purified water, 30.0-60.0% by weight of ethanol and tris-(hydroxymethyl)-aminomethane at pH 5-7.